Hadassah Physicians Unveil Groundbreaking Stem Cell Research
As the founder of Living Epistles Ministry and Christ-Centered Kabbalah, Sheila R. Vitale has published several books, videos, and audio lectures offering insight into Christian doctrine and spiritual development. Operating out of Port Jefferson Station, New York, Sheila Vitale balances her responsibilities as an author and pastor with her support of nonprofit organizations such as Hadassah.
Hadassah, or the Women’s Zionist Organization of America, has provided over a century of service to the global Jewish community. Founded with the goal of mobilizing Jewish women to support and enrich their communities, Hadassah’s mission encompasses the Hadassah Medical Organization (HMO). Based in Jerusalem, HMO delivers life-saving, innovative medical care to over 1 million patients per year at Hadassah Mount Scopus community hospital, the Hadassah Ein Kerem tertiary center, and the Hadassah-Hebrew University School of Medicine.
Recently, two Hadassah Medical Organization physicians attended the 12th Annual World Stem Cell Summit to share their recent progress in the treatment of neurodegenerative diseases and cell-based therapies. Presented by the Regenerative Medicine Foundation in Palm Beach, Florida, the summit served as an ideal forum for HMO senior neurologist Professor Dimitrios Karussis to report on the success of his most recent ALS clinical trial, which yielded positive results for 87 percent of participants exposed to harvested stem cell infusion therapy. These patients included Malia Litman, who attended the summit to personally discuss the incredible physical improvement she experienced after only three stem cell treatment sessions.
Also in attendance was Professor Raphael Gorodetsky, whose groundbreaking research in the realm of cell-based therapy has informed a new placental stem cell treatment, known as PLX-R18, for acute radiation syndrome. Currently the subject of multiple Food and Drug Administration-approved clinical trials, this new medical product also has the potential to speed up bone marrow regeneration for bone marrow transplant patients.